JP2013534527A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013534527A5 JP2013534527A5 JP2013516909A JP2013516909A JP2013534527A5 JP 2013534527 A5 JP2013534527 A5 JP 2013534527A5 JP 2013516909 A JP2013516909 A JP 2013516909A JP 2013516909 A JP2013516909 A JP 2013516909A JP 2013534527 A5 JP2013534527 A5 JP 2013534527A5
- Authority
- JP
- Japan
- Prior art keywords
- panthenol
- use according
- pharmaceutical composition
- contact lens
- dry weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims 16
- 229940101267 panthenol Drugs 0.000 claims 13
- 235000020957 pantothenol Nutrition 0.000 claims 13
- 239000011619 pantothenol Substances 0.000 claims 13
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 239000004480 active ingredient Substances 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 201000005675 papillary conjunctivitis Diseases 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 2
- 230000000172 allergic effect Effects 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 208000030533 eye disease Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2010902954A AU2010902954A0 (en) | 2010-07-02 | Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease | |
| AU2010902954 | 2010-07-02 | ||
| PCT/AU2011/000827 WO2012000055A1 (en) | 2010-07-02 | 2011-07-01 | Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013534527A JP2013534527A (ja) | 2013-09-05 |
| JP2013534527A5 true JP2013534527A5 (enExample) | 2014-08-21 |
Family
ID=45401233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013516909A Pending JP2013534527A (ja) | 2010-07-02 | 2011-07-01 | コンタクトレンズ乳頭結膜炎及びアレルギー性眼疾患の予防及び処置のための組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US9161923B2 (enExample) |
| EP (1) | EP2588096A4 (enExample) |
| JP (1) | JP2013534527A (enExample) |
| CN (1) | CN103037858A (enExample) |
| AU (1) | AU2011274245B2 (enExample) |
| CA (1) | CA2803935A1 (enExample) |
| SG (1) | SG186782A1 (enExample) |
| TW (1) | TW201206418A (enExample) |
| WO (1) | WO2012000055A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101801521B (zh) | 2007-05-14 | 2015-06-17 | 纽约州立大学研究基金会 | 生物膜中细菌细胞内的生理学分散响应诱导 |
| US9161923B2 (en) * | 2010-07-02 | 2015-10-20 | Brien Holden Vision Institute | Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease |
| AR089518A1 (es) * | 2012-12-27 | 2014-08-27 | Vega Villavicencio Parsival | Costra artificial porosa semipermeable |
| PT2898888T (pt) * | 2014-01-22 | 2019-07-16 | Visufarma B V | Composição que compreende iota-carragenina contra conjuntivite viral |
| CA2945604C (en) * | 2014-08-08 | 2022-08-23 | Shenzhen Hightide Biopharmaceutical, Ltd. | Liquid formulation compositions, medicament delivery devices, and methods of preparation and use thereof |
| EP3072503B1 (en) * | 2015-03-26 | 2020-09-23 | D.M.G. Italia Srl | Ophthalmic composition for the corneal protection |
| EP3496516B1 (en) | 2017-12-11 | 2020-02-19 | Ion Beam Applications S.A. | Superconductor cyclotron regenerator |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| EP3827818A1 (en) * | 2019-11-26 | 2021-06-02 | Warszawskie Zaklady Farmaceutyczne Polfa S.A. | Ophthalmic composition |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9914813A (pt) * | 1998-10-27 | 2001-07-03 | Alcon Lab Inc | Sistema conservante para composições farmacêuticas administráveis topicamente |
| US20070104744A1 (en) * | 2000-11-08 | 2007-05-10 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions containing forms of vitamin b |
| DE60203691T3 (de) * | 2001-01-09 | 2011-08-18 | Louis Johan Wagenaar | Verwendung von Dexpanthenol in Kontaktlinsenpflegezusammensetzungen |
| AR034200A1 (es) * | 2001-01-12 | 2004-02-04 | Novartis Ag | Agente para el cuidado de lentes de contacto, su uso, y procedimiento de limpieza |
| DE10161110A1 (de) * | 2001-12-12 | 2003-06-26 | Ursapharm Arzneimittel Gmbh | Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung |
| US20050220742A1 (en) | 2004-03-31 | 2005-10-06 | Breen Ed V | Compositions and methods for maintaining eyelid hygiene |
| US20070243275A1 (en) | 2006-04-13 | 2007-10-18 | Gilbard Jeffrey P | Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear |
| WO2009094466A2 (en) * | 2008-01-22 | 2009-07-30 | University Of Florida Research Foundation, Inc. | Contact lenses for extended release of bioactive agents containing diffusion attenuators |
| US20100087550A1 (en) * | 2008-10-06 | 2010-04-08 | Zora Marlowe | Formulations with a Tertiary Amine Oxide |
| NL2002214C2 (en) * | 2008-11-17 | 2010-05-18 | Louis Johan Wagenaar | Contact lens care solution. |
| AU2010242866B2 (en) | 2009-05-01 | 2014-09-25 | Medtech Products Inc. | Cleanser compositions and methods for using the same |
| IT1393712B1 (it) | 2009-05-13 | 2012-05-08 | Bruschettini Srl | Composizioni oftalmiche per la riepitelizzazione, la cicatrizzazione, e la disinfezione dei tessuti oculari |
| US9161923B2 (en) * | 2010-07-02 | 2015-10-20 | Brien Holden Vision Institute | Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease |
-
2011
- 2011-07-01 US US13/806,249 patent/US9161923B2/en active Active
- 2011-07-01 SG SG2012094140A patent/SG186782A1/en unknown
- 2011-07-01 CA CA2803935A patent/CA2803935A1/en not_active Abandoned
- 2011-07-01 JP JP2013516909A patent/JP2013534527A/ja active Pending
- 2011-07-01 WO PCT/AU2011/000827 patent/WO2012000055A1/en not_active Ceased
- 2011-07-01 CN CN2011800379582A patent/CN103037858A/zh active Pending
- 2011-07-01 TW TW100123320A patent/TW201206418A/zh unknown
- 2011-07-01 EP EP11799986.2A patent/EP2588096A4/en not_active Withdrawn
- 2011-07-01 AU AU2011274245A patent/AU2011274245B2/en not_active Ceased
-
2015
- 2015-09-18 US US14/858,787 patent/US20160074345A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013534527A5 (enExample) | ||
| BR112014008789A2 (pt) | prevenção e tratamento de condições oculares | |
| MX2016014634A (es) | Compuestos para el tratamiento de enfermedades y trastornos oftalmicos. | |
| JP2012533517A5 (enExample) | ||
| FI3811943T3 (fi) | Yhdiste käytettäväksi silmäsairauksien hoidossa | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| EA201492290A1 (ru) | Составы и способы для вагинальной доставки антипрогестинов | |
| JP2012107034A5 (enExample) | ||
| EP2750660A4 (en) | DELAYED RELEASE OF AGENTS FOR THE TREATMENT OF GLUCKOM OR OCCULAR HYPERTONIA | |
| BR112013032122A2 (pt) | liberação modificada de 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)fenil] benzamida solubilizada usando ácidos orgânicos | |
| BR112015029491A2 (pt) | derivados de imidazopirrolidinona e seu uso no tratamento de doença | |
| JP2015057451A5 (enExample) | ||
| BR112015021334A2 (pt) | formulações oculares para entrega de droga ao segmento posterior do olho | |
| BR112015019039A2 (pt) | antagonistas de integrina fluorados | |
| JP2013520405A5 (enExample) | ||
| NZ708526A (en) | Novel rock inhibitors | |
| MX2019013799A (es) | Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo. | |
| RU2013150861A (ru) | Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний | |
| RU2014125426A (ru) | Защитное средство для роговицы и конъюнктивы или супрессивное средство при кератоконъюнктивальном нарушении | |
| JP2016531949A5 (enExample) | ||
| AR088585A1 (es) | Un medicamento para tratar la enfermedad del ojo anterior | |
| WO2018005801A3 (en) | Novel non-systemic tgr5 agonists | |
| JP2013518051A5 (enExample) | ||
| RU2018102746A (ru) | Офтальмологическая фармацевтическая композиция | |
| WO2015048503A3 (en) | N-arylmethyl sulfonamide negative modulators of nr2a |